nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—CHRM3—nephrolithiasis	0.901	1	CbGaD
Scopolamine—CHRM4—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00859	0.113	CbGpPWpGaD
Scopolamine—CHRM5—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00822	0.109	CbGpPWpGaD
Scopolamine—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00579	0.0764	CbGpPWpGaD
Scopolamine—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00572	0.0754	CbGpPWpGaD
Scopolamine—CHRM3—ureter—nephrolithiasis	0.00354	0.781	CbGeAlD
Scopolamine—SI—Carbohydrate metabolism—SLC26A1—nephrolithiasis	0.00235	0.031	CbGpPWpGaD
Scopolamine—Methylscopolamine bromide—CHRM3—nephrolithiasis	0.00221	0.26	CrCbGaD
Scopolamine—CHRM4—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0019	0.025	CbGpPWpGaD
Scopolamine—CHRM5—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00182	0.024	CbGpPWpGaD
Scopolamine—Hyoscyamine—CHRM3—nephrolithiasis	0.00173	0.203	CrCbGaD
Scopolamine—Homatropine Methylbromide—CHRM3—nephrolithiasis	0.00163	0.192	CrCbGaD
Scopolamine—CHRM4—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0016	0.021	CbGpPWpGaD
Scopolamine—CHRM5—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00153	0.0202	CbGpPWpGaD
Scopolamine—Atropine—CHRM3—nephrolithiasis	0.00147	0.173	CrCbGaD
Scopolamine—Ipratropium bromide—CHRM3—nephrolithiasis	0.00146	0.171	CrCbGaD
Scopolamine—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00128	0.0169	CbGpPWpGaD
Scopolamine—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00126	0.0167	CbGpPWpGaD
Scopolamine—CHRM4—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00116	0.0154	CbGpPWpGaD
Scopolamine—CHRM5—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00111	0.0147	CbGpPWpGaD
Scopolamine—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00108	0.0142	CbGpPWpGaD
Scopolamine—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00106	0.014	CbGpPWpGaD
Scopolamine—CHRM4—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000808	0.0107	CbGpPWpGaD
Scopolamine—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000784	0.0104	CbGpPWpGaD
Scopolamine—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000782	0.0103	CbGpPWpGaD
Scopolamine—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000774	0.0102	CbGpPWpGaD
Scopolamine—SI—Metabolism—GRHPR—nephrolithiasis	0.000735	0.0097	CbGpPWpGaD
Scopolamine—SI—Disease—SLC26A1—nephrolithiasis	0.000665	0.00878	CbGpPWpGaD
Scopolamine—SI—Metabolism—AGXT—nephrolithiasis	0.000655	0.00865	CbGpPWpGaD
Scopolamine—CHRM5—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000627	0.00828	CbGpPWpGaD
Scopolamine—SI—Disease—ATP6V0A4—nephrolithiasis	0.000593	0.00783	CbGpPWpGaD
Scopolamine—CHRM4—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000568	0.0075	CbGpPWpGaD
Scopolamine—CHRM4—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000568	0.0075	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000561	0.00741	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000561	0.0074	CbGpPWpGaD
Scopolamine—SI—Metabolism—SLC26A1—nephrolithiasis	0.000557	0.00735	CbGpPWpGaD
Scopolamine—SI—Metabolism—APRT—nephrolithiasis	0.000557	0.00735	CbGpPWpGaD
Scopolamine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.000548	0.0513	CcSEcCtD
Scopolamine—CHRM5—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000544	0.00718	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000544	0.00718	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000538	0.0071	CbGpPWpGaD
Scopolamine—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.000478	0.0447	CcSEcCtD
Scopolamine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00046	0.043	CcSEcCtD
Scopolamine—CHRM5—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000454	0.00599	CbGpPWpGaD
Scopolamine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00045	0.0422	CcSEcCtD
Scopolamine—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000442	0.00583	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00044	0.00581	CbGpPWpGaD
Scopolamine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000421	0.0394	CcSEcCtD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000406	0.00535	CbGpPWpGaD
Scopolamine—SI—Metabolism—AQP1—nephrolithiasis	0.000397	0.00524	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000395	0.00521	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000394	0.0052	CbGpPWpGaD
Scopolamine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00039	0.0365	CcSEcCtD
Scopolamine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000385	0.036	CcSEcCtD
Scopolamine—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000383	0.00506	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000383	0.00506	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000378	0.00499	CbGpPWpGaD
Scopolamine—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000378	0.00499	CbGpPWpGaD
Scopolamine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.000367	0.0344	CcSEcCtD
Scopolamine—CHRM4—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000366	0.00483	CbGpPWpGaD
Scopolamine—SI—Metabolism—CHRM3—nephrolithiasis	0.000359	0.00474	CbGpPWpGaD
Scopolamine—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000358	0.0335	CcSEcCtD
Scopolamine—CHRM5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000351	0.00463	CbGpPWpGaD
Scopolamine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.000347	0.0325	CcSEcCtD
Scopolamine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000335	0.0313	CcSEcCtD
Scopolamine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000322	0.0302	CcSEcCtD
Scopolamine—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000319	0.00422	CbGpPWpGaD
Scopolamine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000314	0.0294	CcSEcCtD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000314	0.00414	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0003	0.00396	CbGpPWpGaD
Scopolamine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000296	0.0277	CcSEcCtD
Scopolamine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000294	0.0275	CcSEcCtD
Scopolamine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000288	0.027	CcSEcCtD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000286	0.00377	CbGpPWpGaD
Scopolamine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000282	0.0264	CcSEcCtD
Scopolamine—CHRM3—renal system—nephrolithiasis	0.000281	0.0621	CbGeAlD
Scopolamine—CHRM4—GPCR downstream signaling—RGS14—nephrolithiasis	0.000276	0.00365	CbGpPWpGaD
Scopolamine—CHRM3—kidney—nephrolithiasis	0.000272	0.06	CbGeAlD
Scopolamine—CHRM5—GPCR downstream signaling—RGS14—nephrolithiasis	0.000265	0.00349	CbGpPWpGaD
Scopolamine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000261	0.0245	CcSEcCtD
Scopolamine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000258	0.0242	CcSEcCtD
Scopolamine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000256	0.024	CcSEcCtD
Scopolamine—CHRM4—Signaling by GPCR—RGS14—nephrolithiasis	0.000251	0.00331	CbGpPWpGaD
Scopolamine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00025	0.0234	CcSEcCtD
Scopolamine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000248	0.0232	CcSEcCtD
Scopolamine—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000247	0.00326	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000244	0.00322	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—RGS14—nephrolithiasis	0.00024	0.00317	CbGpPWpGaD
Scopolamine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000239	0.0224	CcSEcCtD
Scopolamine—CHRM4—GPCR ligand binding—CHRM3—nephrolithiasis	0.000239	0.00315	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—CHRM3—nephrolithiasis	0.000229	0.00302	CbGpPWpGaD
Scopolamine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000228	0.0213	CcSEcCtD
Scopolamine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000221	0.0207	CcSEcCtD
Scopolamine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000219	0.0205	CcSEcCtD
Scopolamine—Pain—Hydrochlorothiazide—nephrolithiasis	0.000219	0.0205	CcSEcCtD
Scopolamine—CHRM4—GPCR ligand binding—PTH—nephrolithiasis	0.000219	0.00288	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000213	0.00281	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000213	0.00281	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000212	0.00279	CbGpPWpGaD
Scopolamine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000211	0.0198	CcSEcCtD
Scopolamine—CHRM5—GPCR ligand binding—PTH—nephrolithiasis	0.000209	0.00276	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000209	0.00276	CbGpPWpGaD
Scopolamine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000203	0.019	CcSEcCtD
Scopolamine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000203	0.019	CcSEcCtD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00019	0.00251	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—DGKH—nephrolithiasis	0.000187	0.00246	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000186	0.00246	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000186	0.00245	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000184	0.00243	CbGpPWpGaD
Scopolamine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000184	0.0172	CcSEcCtD
Scopolamine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000181	0.017	CcSEcCtD
Scopolamine—CHRM5—GPCR downstream signaling—DGKH—nephrolithiasis	0.000179	0.00236	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ADCY10—nephrolithiasis	0.000174	0.0023	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000174	0.00229	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000174	0.00229	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—DGKH—nephrolithiasis	0.00017	0.00224	CbGpPWpGaD
Scopolamine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000169	0.0159	CcSEcCtD
Scopolamine—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.000169	0.00223	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000169	0.00223	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000167	0.00221	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ADCY10—nephrolithiasis	0.000167	0.0022	CbGpPWpGaD
Scopolamine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000163	0.0152	CcSEcCtD
Scopolamine—CHRM5—Signaling by GPCR—DGKH—nephrolithiasis	0.000162	0.00214	CbGpPWpGaD
Scopolamine—Rash—Hydrochlorothiazide—nephrolithiasis	0.000162	0.0151	CcSEcCtD
Scopolamine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000161	0.0151	CcSEcCtD
Scopolamine—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000161	0.00213	CbGpPWpGaD
Scopolamine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00016	0.015	CcSEcCtD
Scopolamine—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000159	0.0021	CbGpPWpGaD
Scopolamine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000152	0.0142	CcSEcCtD
Scopolamine—CHRM4—Signaling Pathways—RGS14—nephrolithiasis	0.000148	0.00196	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000147	0.00194	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000147	0.00194	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000145	0.00192	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	0.000142	0.00187	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000135	0.00178	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000132	0.00174	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000132	0.00174	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000129	0.00171	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000126	0.00166	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000126	0.00166	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000124	0.00164	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—PTH—nephrolithiasis	0.000123	0.00163	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CHRM3—nephrolithiasis	0.000123	0.00162	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000122	0.00162	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000122	0.00162	CbGpPWpGaD
Scopolamine—ABCB1—nephron tubule—nephrolithiasis	0.00012	0.0266	CbGeAlD
Scopolamine—CHRM3—Metabolism—GRHPR—nephrolithiasis	0.000119	0.00157	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	0.000118	0.00156	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000118	0.00155	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	0.000117	0.00155	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	0.000117	0.00155	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.000116	0.00153	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.000114	0.00151	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	0.000114	0.0015	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	0.000113	0.00149	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	0.000112	0.00148	CbGpPWpGaD
Scopolamine—ABCB1—renal system—nephrolithiasis	0.000109	0.0242	CbGeAlD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000109	0.00144	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000109	0.00144	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	0.000107	0.00142	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AGXT—nephrolithiasis	0.000106	0.0014	CbGpPWpGaD
Scopolamine—ABCB1—kidney—nephrolithiasis	0.000106	0.0234	CbGeAlD
Scopolamine—ABCB1—cortex of kidney—nephrolithiasis	0.000103	0.0227	CbGeAlD
Scopolamine—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	0.0001	0.00132	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0001	0.00132	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	0.0001	0.00132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	9.97e-05	0.00132	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	9.87e-05	0.0013	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	9.59e-05	0.00127	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	9.59e-05	0.00127	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	9.1e-05	0.0012	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—SLC26A1—nephrolithiasis	9.03e-05	0.00119	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APRT—nephrolithiasis	9.03e-05	0.00119	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	8.99e-05	0.00119	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	8.72e-05	0.00115	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	8.33e-05	0.0011	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	8.3e-05	0.0011	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	8.27e-05	0.00109	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	8.22e-05	0.00108	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	8.16e-05	0.00108	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GRHPR—nephrolithiasis	7.56e-05	0.000998	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	7.56e-05	0.000998	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	7.54e-05	0.000995	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	7.46e-05	0.000985	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	7.24e-05	0.000956	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	6.94e-05	0.000915	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.75e-05	0.000891	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	6.75e-05	0.000891	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AGXT—nephrolithiasis	6.74e-05	0.00089	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	6.73e-05	0.000889	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.73e-05	0.000889	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.67e-05	0.00088	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	6.67e-05	0.00088	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTH—nephrolithiasis	6.62e-05	0.000874	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AQP1—nephrolithiasis	6.44e-05	0.00085	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTH—nephrolithiasis	6.34e-05	0.000837	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APRT—nephrolithiasis	5.73e-05	0.000756	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	5.73e-05	0.000756	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	4.88e-05	0.000644	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	4.82e-05	0.000636	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTH—nephrolithiasis	4.47e-05	0.000589	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTH—nephrolithiasis	4.45e-05	0.000588	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTH—nephrolithiasis	4.41e-05	0.000582	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AQP1—nephrolithiasis	4.08e-05	0.000539	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CHRM3—nephrolithiasis	3.69e-05	0.000487	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	3.33e-05	0.000439	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	3.18e-05	0.00042	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	2.24e-05	0.000296	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	2.24e-05	0.000295	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	2.21e-05	0.000292	CbGpPWpGaD
